Stay updated on Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page.

Latest updates to the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website’s displayed revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedA site-wide NIH notice says agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to transition updates and FAQs.SummaryDifference0.7%

- Check26 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRecord history shows the page now references revision v3.7.0, replacing the previous v3.6.6. This indicates an updated version of the ClinicalTrials.gov interface applied to this study record history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry, v3.6.6, has been added to the history. The previous revision v3.6.5 is superseded by the new version, reflecting an update to the study record.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page.